TRI-CON 2024: Over 30 Years of Driving Innovation and Collaboration in Diagnostics and Precision Medicine

For 3 decades, the Precision Med TRI-CON has served as the leading international meeting place for the diagnostics and precision medicine community. Join thousands of international thought leaders to discuss the latest research, technologies, innovation and business models in implementing precision medicine, biomarkers and companion diagnostics, genomic medicine, and precision health; innovation and market access strategies for at-home diagnostics, point-of-care testing and molecular diagnostics for infectious diseases; liquid biopsy and advanced diagnostics for precision oncology, including multi-cancer early detection and minimal residual disease testing. Emerging implications of faster and cheaper sequencing, AI and digital tools, rare disease diagnostics and gene therapies, and spatial biology and single-cell multiomics in advancing precision medicine will be covered in 2024. Join us in sunny San Diego for the in-person networking and visionary and thought-provoking keynote discussions you’ve come to expect from the TRI-CON!


2023 Featured Speakers

J. Craig Venter

Celebrating 30 Years of Genomics Innovation

FIRESIDE CHAT: Sequences, SynBio, and Sailing: Three Decades of Adventure with J. Craig Venter

J. Craig Venter, PhD, Founder, Chairman, and CEO, J. Craig Venter Institute


EuQan Ashley

Euan Ashley
Professor, Genomics & Precision Health
Stanford

Molly He

Molly He
CEO
Element Bioscience

Alex Aravanis

Alex Aravanis
CTO
Illumina

Sarah Hersey

Sarah Hersey
VP, Precision Medicine
Bristol Myers Squibb

Bruce J. Tromberg

Bruce J. Tromberg
Director
National Institute of Biomedical Imaging and Bioengineering, NIH

Mara Aspinall

Mara Aspinall
Managing Director
BlueStone Venture Partners

Stephen F. Kingsmore

Stephen F. Kingsmore
President & CEO
Rady Children’s Institute for Genomic Medicine

Esther Babady

Esther Babady
Section Head, Clinical Microbiology
Memorial Sloan Kettering Cancer Center

Eric Dishman

Eric Dishman
Former Director, All of Us Research Program
NIH

Alicyn Campbell

Alicyn Campbell
Head, Digital Health Oncology
AstraZeneca

Christopher M. Hartshorn

Christopher M. Hartshorn
Chief, Digital & Mobile Technologies
NCATS, NIH

Razelle Kurzrock

Razelle Kurzrock
Chair, Clinical Trials Committee
WIN for Personalized Cancer Therapy

Howard I. Scher

Howard I. Scher
Head, Biomarker Development
Memorial Sloan Kettering Cancer Center

Jacqueline Shreibati

Jacqueline Shreibati
Senior Clinical Lead, Consumer Health
Google

Tom Miller

Tom Miller
Managing Partner
GreyBird Ventures

Lourdes Barrera

Lourdes Barrera
Executive Director, Precision Medicine
Merck

Philip E. Castle

Philip E. Castle
Director, Cancer Prevention
NCI, NIH

Hoi-Ying Elsie Yu

Hoi-Ying Elsie Yu
Director, Point-of-Care Testing
Geisinger Health System

Nathan Ledeboer

Nathan Ledeboer
Vice Chair, Pathology
Medical College of Wisconsin

Michael Snyder

Michael Snyder
Director, Genomics & Personalized Medicine
Stanford University

Edward Abrahams

Edward Abrahams
President
Personalized Medicine Coalition

Marielena Mata

Marielena Mata
Diagnostic Lead, Oncology
Pfizer

Christopher Conn

Christopher Conn
Global Director, Diagnostics Strategy
Amgen

Larry Kessler

Larry Kessler
Deputy Chair
MCED Consortium

Kenna R. Mills-Shaw

Kenna R. Mills-Shaw
Executive Director, Personalized Cancer Therapy
MD Anderson Cancer Center

Dave Persing

Dave Persing
CSO, Cepheid
CSO, Danaher Diagnostics

Cindy Perettie

Cindy Perettie
Head
Roche Molecular Labs

William G. Morice II

William G. Morice II
CEO
Mayo Clinic Laboratories

Robert J. Bujarski

Robert J. Bujarski
President and COO
QuidelOrtho

Jay Wohlgemuth

Jay Wohlgemuth
CMO
Quest Diagnostics

Key Contacts

PARTNERING AND SPONSORSHIP

Jon Stroup

Companies A-K
Jon Stroup
Senior Business Development Manager
Cambridge Healthtech Institute
781-972-5483
jstroup@healthtech.com

Katelin Fitzgerald

Companies L-Z
Katelin Fitzgerald
Sr. Manager, Business Development
Cambridge Healthtech Institute
781-247-1824
kfitzgerald@cambridgeinnovationinstitute.com

Julia Boguslavsky

For meeting questions or suggestions, please contact:
Julia Boguslavsky
Executive Director, Conferences
Cambridge Healthtech Institute
juliab@healthtech.com

Rich Handy

For media and association partnerships, please contact:
Rich Handy
Senior Director of Marketing
Cambridge Healthtech Institute
781-972-5456
rhandy@healthtech.com